Peizhen Hu
- Biochemistry top 2%
- Lipid metabolism and biosynthesis 8
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Hepatology top 10%
- Molecular Biology top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 6
-
- Cancer Cells and Metastasis 8
-
- Cancer, Stress, Anesthesia, and Immune Response 4
-
- Cancer Research and Treatments 4
-
- Adipose Tissue and Metabolism 4
-
- Prostate Cancer Treatment and Research 4
- Co-authors
- Yi‐Ting ChenXiangyan LiHaiyen E. ZhauLeland W.K. ChungWen‐Chin HuangChen ShaoZengshan LiRuoxiang Wang
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Peizhen Hu
54 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 108
- Biochemistry 265
- Cancer Research 461
- Hepatology 107
- Molecular Biology 817
- Immunology 240
Countries citing papers authored by Peizhen Hu
This map shows the geographic impact of Peizhen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peizhen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peizhen Hu more than expected).
Fields of papers citing papers by Peizhen Hu
This network shows the impact of papers produced by Peizhen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peizhen Hu. The network helps show where Peizhen Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peizhen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 13 | |
| 4 | 2020 | 18 | |
| 5 | 2019 | 10 | |
| 6 | 2019 | 39 | |
| 7 | 2018 | 14 | |
| 8 | 2017 | 12 | |
| 9 | 2017 | 71 | |
| 10 | 2016 | 55 | |
| 11 | 2014 | 156 | |
| 12 | 2014 | 118 | |
| 13 | 2014 | 18 | |
| 14 | 2011 | 4 | |
| 15 | 2008 | 10 | |
| 16 | 2008 | 8 | |
| 17 | 2007 | 22 | |
| 18 | 2007 | 3 | |
| 19 | 2006 | 11 | |
| 20 | 2005 | 14 |
About Peizhen Hu
Peizhen Hu is a scholar working on Biochemistry, Cancer Research and Oncology, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Lipid metabolism and biosynthesis (8 papers), Immunotherapy and Immune Responses (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Cancer Research and Treatments (4 papers), Adipose Tissue and Metabolism (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Biochemistry (265 citations), Cancer Research (461 citations) and Hepatology (107 citations). Peizhen Hu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yi‐Ting Chen, Xiangyan Li, Haiyen E. Zhau, Leland W.K. Chung, Wen‐Chin Huang, Chen Shao, Zengshan Li, Ruoxiang Wang, Jing Ye and Lijun Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports, Oncotarget, Lipids in Health and Disease and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.